Literature DB >> 27411747

A longitudinal study on anxiety, depressive and adjustment disorder, suicide ideation and symptoms of emotional distress in patients with cancer undergoing radiotherapy.

Manuel Hernández Blázquez1, Juan Antonio Cruzado2.   

Abstract

BACKGROUND: The aim of this study is to evaluate the presence of anxiety, depressive and adjustment disorders, suicide ideation, and symptoms of anxiety and depression in patients with cancer before (T1), and after radiotherapy (T2) and at the 1-month follow-up (T3).
METHODS: A longitudinal study on 103 patients with cancer treated as outpatients undergoing radiotherapy was carried out, evaluating them three times (T1-T2-T3) according to DSM-IV criteria with the Mini-International Neuropsychiatric Interview and the Hospital Anxiety and Depression Scale.
RESULTS: Prevalence of the depressive disorders was: T1=6.8%, T2=3.9% and T3=3.9%; for anxiety disorders: T1=16.5%, T2=18.4% and T3=16.5%; for adjustment disorder: 10.7%, 5.8% and 7.8%; and for suicide ideation: T1=11.7%, T2=7.8% and T3=7.8%. In all, the presence of disorders was: T1=35%, T2=26.2%0.4% and T3=29.1%. At least one mental disorder was diagnosed in 46.6% of patients in one of the three times of the study. In relation to the symptoms, the prevalence of the possible cases of clinical anxiety was: T1=35.9%, T2=18.4% and T3=22.3%; the prevalence of possible cases of clinical depression was 19.4%, 16.5% and 10.7%, respectively; and the prevalence of emotional distress was 27.2%, 17.5% and 18.4%, respectively. All symptoms decreased significantly from T1 to T2 and from T1 to T3, with moderate effect sizes. No changes were observed between the end of the radiotherapy and the follow-up period.
CONCLUSIONS: High prevalence of mental disorders and symptoms of anxiety, depression and distress were observed in the patients with cancer before finishing radiotherapy treatment and during the follow-up. FUNDING: Basurto University Hospital and Basque Foundation for Innovation and Research in Health-BIOEF.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjustment disorder; Anxiety disorder; Cancer; Depression disorder; Distress; HADS; Radiotherapy; Suicide ideation

Mesh:

Year:  2016        PMID: 27411747     DOI: 10.1016/j.jpsychores.2016.05.010

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  16 in total

1.  Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy.

Authors:  P Jimenez-Fonseca; C Calderón; R Hernández; T Ramón Y Cajal; M Mut; A Ramchandani; O Donnay; A Carmona-Bayonas
Journal:  Clin Transl Oncol       Date:  2018-04-12       Impact factor: 3.405

2.  Neurological Impairments in Mice Subjected to Irradiation and Chemotherapy.

Authors:  Deblina Dey; Vipan K Parihar; Gergely G Szabo; Peter M Klein; Jenny Tran; Jonathan Moayyad; Faizy Ahmed; Quynh-Anh Nguyen; Alexandria Murry; David Merriott; Brandon Nguyen; Jodi Goldman; Maria C Angulo; Daniele Piomelli; Ivan Soltesz; Janet E Baulch; Charles L Limoli
Journal:  Radiat Res       Date:  2020-03-05       Impact factor: 2.841

3.  Associations of BNIP3 and DAPK1 gene polymorphisms with disease susceptibility, clinicopathologic features, anxiety, and depression in gastric cancer patients.

Authors:  Xiaoqi Lou; Dingtao Hu; Zhen Li; Ying Teng; Qiuyue Lou; Shunwei Huang; Yanfeng Zou; Fang Wang
Journal:  Int J Clin Exp Pathol       Date:  2021-05-15

4.  Mental disorder screening on cancer patients before and after radiotherapy and at the 1-month follow-up.

Authors:  Juan Antonio Cruzado; Manuel Hernández-Blázquez
Journal:  Support Care Cancer       Date:  2017-09-23       Impact factor: 3.603

Review 5.  Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

Authors:  Nina Schimmel; Joost J Breeksema; Sanne Y Smith-Apeldoorn; Jolien Veraart; Wim van den Brink; Robert A Schoevers
Journal:  Psychopharmacology (Berl)       Date:  2021-11-23       Impact factor: 4.530

6.  Leptin-LepRb Expressed in Gastric Cancer Patients and Related to Cancer-Related Depression.

Authors:  Yunbao Pan; Fuling Zhou; Chenyan He; Lingyun Hui; Tianhe Huang; Yongchang Wei
Journal:  Biomed Res Int       Date:  2017-02-20       Impact factor: 3.411

7.  An internet-based intervention for adjustment disorder (TAO): study protocol for a randomized controlled trial.

Authors:  Iryna Rachyla; Marian Pérez-Ara; Mar Molés; Daniel Campos; Adriana Mira; Cristina Botella; Soledad Quero
Journal:  BMC Psychiatry       Date:  2018-05-31       Impact factor: 3.630

8.  Group interventions to reduce emotional distress and fatigue in breast cancer patients: a 9-month follow-up pragmatic trial.

Authors:  Charlotte Grégoire; Isabelle Bragard; Guy Jerusalem; Anne-Marie Etienne; Philippe Coucke; Gilles Dupuis; Dominique Lanctôt; Marie-Elisabeth Faymonville
Journal:  Br J Cancer       Date:  2017-09-19       Impact factor: 7.640

9.  Randomized controlled trial of an 8-week intervention combining self-care and hypnosis for post-treatment cancer patients: study protocol.

Authors:  Charlotte Grégoire; Marie-Elisabeth Faymonville; Audrey Vanhaudenhuyse; Vanessa Charland-Verville; Guy Jerusalem; Isabelle Bragard
Journal:  BMC Cancer       Date:  2018-11-15       Impact factor: 4.430

10.  Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients.

Authors:  C Grégoire; H Nicolas; I Bragard; F Delevallez; I Merckaert; D Razavi; D Waltregny; M-E Faymonville; A Vanhaudenhuyse
Journal:  BMC Cancer       Date:  2018-06-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.